Compare LEN & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEN | RVTY |
|---|---|---|
| Founded | 1954 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.1B | 17.0B |
| IPO Year | 1996 | 1994 |
| Metric | LEN | RVTY |
|---|---|---|
| Price | $84.81 | $158.18 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 21 | 18 |
| Target Price | $77.87 | ★ $147.53 |
| AVG Volume (30 Days) | ★ 4.9M | 1.5M |
| Earning Date | 09-16-2026 | 11-03-2026 |
| Dividend Yield | ★ 2.37% | 0.18% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.36 | 0.82 |
| Revenue | ★ $34,186,934,000.00 | $3,311,822,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.98 | $5.44 |
| P/E Ratio | ★ $25.12 | $191.17 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $71.78 | $81.22 |
| 52 Week High | $133.76 | $166.25 |
| Indicator | LEN | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 60.81 | 65.19 |
| Support Level | $82.48 | $146.70 |
| Resistance Level | $89.39 | $166.25 |
| Average True Range (ATR) | 2.70 | 6.24 |
| MACD | 1.06 | -0.54 |
| Stochastic Oscillator | 100.00 | 59.85 |
Lennar is the second-largest public homebuilder in the United States, behind D.R. Horton, operating in 26 states. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily construction and has invested in numerous housing-related technology startups.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.